Strengthening health literacy among Indigenous people living with cardiovascular disease, their families, and health care providers
- Conditions
- Cardiovascular diseasePublic Health - Health service researchPublic Health - Health promotion/educationCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12612001309875
- Lead Sponsor
- Dr Sue Crengle
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 440
Member of indigenous ethnic group who have been diagnosed with angina pectoris, myocardial infarction, transient ischaemic attack or stroke. In Canada participants will also be eligible cardiovascular risk assessment score above the cut off (assessed as being at greater than or equal to 15% risk of experiencing a cardiovascular event in the next 10 years according Framingham General Cardiovascular Risk Assessment Scoring)
AND are taking at least two of the following types of medicines: a statin; Aspirin; a beta blocker; an ACE inhibitor.
Cognitive deficit, such as receptive or expressive aphasia, that interfere with the ability to participate in the intervention will not be eligible for the trial.
Conditions that mean that the person is unable to give informed consent (e.g. acute psychotic illness, dementia).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method